|
|
|
|
MRIPH independently and strongly predicts recurrent ipsilateral ischemic events, and stroke alone, in symptomatic �50% carotid artery stenosis. The very low stroke risk in patients without MRIPH puts into question current risk-benefit assessment for CEA in this subgroup. |
|